Pediatric Cancer Immunotherapy Working Group

8

The mission of the Pediatric Cancer Immunotherapy Working Group is to promote career development of physician-scientists and develop new investigator-initiated immunotherapies while bolstering the submission/securement of pediatric immunotherapy focused program project grants and core resources within veterinary comparative oncology and bioengineering.

Given the dearth of pediatric, adolescent and young adult cancer immunotherapies for high-risk malignancies (i.e. relapsed/refractory extracranial solid tumors, CNS malignancies and AML), the Cancer Center spearheaded the formation of the Pediatric Cancer Immunotherapy Working Group (PCI2) in 2019 to link trainees and/or junior faculty with established investigators to foster career development while enhancing catalysis of pediatric/AYA specific immunotherapies.

For more information about the group, please contact Elias Sayour, M.D., Ph.D., at Elias.Sayour@neurosurgery.ufl.edu.